Samuel is the first Canadian and the ninth patient worldwide to participate in the second phase of a study using gene therapy to treat Glycogen storage disease type I, otherwise known as GSD.

The RI-MUHC is seeking a dynamic and strategic leader to serve as its next Executive Director and Chief Scientific Officer (ED/CSO)

Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

Dermatology resident Abdulhadi Jfri shares his thoughts on undertaking a simultaneous Master’s degree

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

The road towards Canadian testing capacity began in Montreal

Speakers: Dr. Makeda Semret and Dr. Marina Klein

Sixteen new matches made, eight project funded: life sciences researchers meet data scientists

A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis

In this webinar, four panelists will share their personal insights and experiences with the CLSA, showcasing opportunities to engage with Canada’s largest platform for research on aging.

Application Deadline: July 17, 2020

Immunity in our community - how to stay safe in the age of COVID. Since the onset of the COVID-19 pandemic, the main theme at the forefront of everyone’s mind has been safety.

RI-MUHC researcher Abhinav Sharma calls for an approach emphasizing voluntary consent

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality

A new study highlights a strong risk factor for COPD related to lung development

Congratulations to Joseph Mussa!

A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2

The MUHC Foundation is launching a new webinar series!

Report shares participants’ solutions to career development challenges in the life sciences

The Board of Directors of the RI-MUHC is pleased to announce the appointment of Dr. Miguel N. Burnier, Jr. to the position of Interim Executive Director and Chief Scientific Officer of the RI-MUHC

Government support for McGill and RI-MUHC team in COVID-19 testing

RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

“It is not only what you say that matters, but what you do”